Global Influenza Drugs Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Influenza Drugs Industry Forecast” looks at past sales and reviews total world Influenza Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Influenza Drugs sales for 2023 through 2029. With Influenza Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Drugs industry.
This Insight Report provides a comprehensive analysis of the global Influenza Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Influenza Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Drugs.
The global Influenza Drugs market size is projected to grow from US$ 1670.4 million in 2022 to US$ 2114.3 million in 2029; it is expected to grow at a CAGR of 2114.3 from 2023 to 2029.
United States market for Influenza Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Influenza Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Influenza Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Influenza Drugs players cover Bristol-Myers Squibb], AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur and Bayer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Influenza Drugs market?
What factors are driving Influenza Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza Drugs market opportunities vary by end market size?
How does Influenza Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Influenza Drugs Industry Forecast” looks at past sales and reviews total world Influenza Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Influenza Drugs sales for 2023 through 2029. With Influenza Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Influenza Drugs industry.
This Insight Report provides a comprehensive analysis of the global Influenza Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Influenza Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Influenza Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Influenza Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Influenza Drugs.
The global Influenza Drugs market size is projected to grow from US$ 1670.4 million in 2022 to US$ 2114.3 million in 2029; it is expected to grow at a CAGR of 2114.3 from 2023 to 2029.
United States market for Influenza Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Influenza Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Influenza Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Influenza Drugs players cover Bristol-Myers Squibb], AstraZeneca, Eli Lilly, Roche, GlaxoSmithKline, Novartis, Pfizer, Sanofi Pasteur and Bayer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Zanamivir
- Oseltamivir Phosphate
- Peramivir
- Other Influenza Drugs
- Adults
- Chidren
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol-Myers Squibb]
- AstraZeneca
- Eli Lilly
- Roche
- GlaxoSmithKline
- Novartis
- Pfizer
- Sanofi Pasteur
- Bayer
- Celgene
- Seqirus
- Protein Sciences Corporation
- Serum Institute of India
- Emergent Biosolutions
- BioCryst Pharmaceuticals
- Alvogen
What is the 10-year outlook for the global Influenza Drugs market?
What factors are driving Influenza Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Influenza Drugs market opportunities vary by end market size?
How does Influenza Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Influenza Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Influenza Drugs by Country/Region, 2018, 2022 & 2029
2.2 Influenza Drugs Segment by Type
2.2.1 Zanamivir
2.2.2 Oseltamivir Phosphate
2.2.3 Peramivir
2.2.4 Other Influenza Drugs
2.3 Influenza Drugs Sales by Type
2.3.1 Global Influenza Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Influenza Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Influenza Drugs Sale Price by Type (2018-2023)
2.4 Influenza Drugs Segment by Application
2.4.1 Adults
2.4.2 Chidren
2.5 Influenza Drugs Sales by Application
2.5.1 Global Influenza Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Influenza Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Influenza Drugs Sale Price by Application (2018-2023)
3 GLOBAL INFLUENZA DRUGS BY COMPANY
3.1 Global Influenza Drugs Breakdown Data by Company
3.1.1 Global Influenza Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Influenza Drugs Sales Market Share by Company (2018-2023)
3.2 Global Influenza Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Influenza Drugs Revenue by Company (2018-2023)
3.2.2 Global Influenza Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Influenza Drugs Sale Price by Company
3.4 Key Manufacturers Influenza Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza Drugs Product Location Distribution
3.4.2 Players Influenza Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFLUENZA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Influenza Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Influenza Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Influenza Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Influenza Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Influenza Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Influenza Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Influenza Drugs Sales Growth
4.4 APAC Influenza Drugs Sales Growth
4.5 Europe Influenza Drugs Sales Growth
4.6 Middle East & Africa Influenza Drugs Sales Growth
5 AMERICAS
5.1 Americas Influenza Drugs Sales by Country
5.1.1 Americas Influenza Drugs Sales by Country (2018-2023)
5.1.2 Americas Influenza Drugs Revenue by Country (2018-2023)
5.2 Americas Influenza Drugs Sales by Type
5.3 Americas Influenza Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Drugs Sales by Region
6.1.1 APAC Influenza Drugs Sales by Region (2018-2023)
6.1.2 APAC Influenza Drugs Revenue by Region (2018-2023)
6.2 APAC Influenza Drugs Sales by Type
6.3 APAC Influenza Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza Drugs by Country
7.1.1 Europe Influenza Drugs Sales by Country (2018-2023)
7.1.2 Europe Influenza Drugs Revenue by Country (2018-2023)
7.2 Europe Influenza Drugs Sales by Type
7.3 Europe Influenza Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Drugs by Country
8.1.1 Middle East & Africa Influenza Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Influenza Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Influenza Drugs Sales by Type
8.3 Middle East & Africa Influenza Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza Drugs
10.3 Manufacturing Process Analysis of Influenza Drugs
10.4 Industry Chain Structure of Influenza Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza Drugs Distributors
11.3 Influenza Drugs Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA DRUGS BY GEOGRAPHIC REGION
12.1 Global Influenza Drugs Market Size Forecast by Region
12.1.1 Global Influenza Drugs Forecast by Region (2024-2029)
12.1.2 Global Influenza Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Influenza Drugs Forecast by Type
12.7 Global Influenza Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bristol-Myers Squibb]
13.1.1 Bristol-Myers Squibb] Company Information
13.1.2 Bristol-Myers Squibb] Influenza Drugs Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bristol-Myers Squibb] Main Business Overview
13.1.5 Bristol-Myers Squibb] Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Influenza Drugs Product Portfolios and Specifications
13.2.3 AstraZeneca Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Eli Lilly
13.3.1 Eli Lilly Company Information
13.3.2 Eli Lilly Influenza Drugs Product Portfolios and Specifications
13.3.3 Eli Lilly Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Eli Lilly Main Business Overview
13.3.5 Eli Lilly Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Influenza Drugs Product Portfolios and Specifications
13.4.3 Roche Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline Influenza Drugs Product Portfolios and Specifications
13.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Influenza Drugs Product Portfolios and Specifications
13.6.3 Novartis Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Influenza Drugs Product Portfolios and Specifications
13.7.3 Pfizer Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Sanofi Pasteur
13.8.1 Sanofi Pasteur Company Information
13.8.2 Sanofi Pasteur Influenza Drugs Product Portfolios and Specifications
13.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sanofi Pasteur Main Business Overview
13.8.5 Sanofi Pasteur Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Influenza Drugs Product Portfolios and Specifications
13.9.3 Bayer Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 Celgene
13.10.1 Celgene Company Information
13.10.2 Celgene Influenza Drugs Product Portfolios and Specifications
13.10.3 Celgene Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Celgene Main Business Overview
13.10.5 Celgene Latest Developments
13.11 Seqirus
13.11.1 Seqirus Company Information
13.11.2 Seqirus Influenza Drugs Product Portfolios and Specifications
13.11.3 Seqirus Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Seqirus Main Business Overview
13.11.5 Seqirus Latest Developments
13.12 Protein Sciences Corporation
13.12.1 Protein Sciences Corporation Company Information
13.12.2 Protein Sciences Corporation Influenza Drugs Product Portfolios and Specifications
13.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Protein Sciences Corporation Main Business Overview
13.12.5 Protein Sciences Corporation Latest Developments
13.13 Serum Institute of India
13.13.1 Serum Institute of India Company Information
13.13.2 Serum Institute of India Influenza Drugs Product Portfolios and Specifications
13.13.3 Serum Institute of India Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Serum Institute of India Main Business Overview
13.13.5 Serum Institute of India Latest Developments
13.14 Emergent Biosolutions
13.14.1 Emergent Biosolutions Company Information
13.14.2 Emergent Biosolutions Influenza Drugs Product Portfolios and Specifications
13.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Emergent Biosolutions Main Business Overview
13.14.5 Emergent Biosolutions Latest Developments
13.15 BioCryst Pharmaceuticals
13.15.1 BioCryst Pharmaceuticals Company Information
13.15.2 BioCryst Pharmaceuticals Influenza Drugs Product Portfolios and Specifications
13.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 BioCryst Pharmaceuticals Main Business Overview
13.15.5 BioCryst Pharmaceuticals Latest Developments
13.16 Alvogen
13.16.1 Alvogen Company Information
13.16.2 Alvogen Influenza Drugs Product Portfolios and Specifications
13.16.3 Alvogen Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Alvogen Main Business Overview
13.16.5 Alvogen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Influenza Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Influenza Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Influenza Drugs by Country/Region, 2018, 2022 & 2029
2.2 Influenza Drugs Segment by Type
2.2.1 Zanamivir
2.2.2 Oseltamivir Phosphate
2.2.3 Peramivir
2.2.4 Other Influenza Drugs
2.3 Influenza Drugs Sales by Type
2.3.1 Global Influenza Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Influenza Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Influenza Drugs Sale Price by Type (2018-2023)
2.4 Influenza Drugs Segment by Application
2.4.1 Adults
2.4.2 Chidren
2.5 Influenza Drugs Sales by Application
2.5.1 Global Influenza Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Influenza Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Influenza Drugs Sale Price by Application (2018-2023)
3 GLOBAL INFLUENZA DRUGS BY COMPANY
3.1 Global Influenza Drugs Breakdown Data by Company
3.1.1 Global Influenza Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Influenza Drugs Sales Market Share by Company (2018-2023)
3.2 Global Influenza Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Influenza Drugs Revenue by Company (2018-2023)
3.2.2 Global Influenza Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Influenza Drugs Sale Price by Company
3.4 Key Manufacturers Influenza Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza Drugs Product Location Distribution
3.4.2 Players Influenza Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INFLUENZA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Influenza Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Influenza Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Influenza Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Influenza Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Influenza Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Influenza Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Influenza Drugs Sales Growth
4.4 APAC Influenza Drugs Sales Growth
4.5 Europe Influenza Drugs Sales Growth
4.6 Middle East & Africa Influenza Drugs Sales Growth
5 AMERICAS
5.1 Americas Influenza Drugs Sales by Country
5.1.1 Americas Influenza Drugs Sales by Country (2018-2023)
5.1.2 Americas Influenza Drugs Revenue by Country (2018-2023)
5.2 Americas Influenza Drugs Sales by Type
5.3 Americas Influenza Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Drugs Sales by Region
6.1.1 APAC Influenza Drugs Sales by Region (2018-2023)
6.1.2 APAC Influenza Drugs Revenue by Region (2018-2023)
6.2 APAC Influenza Drugs Sales by Type
6.3 APAC Influenza Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Influenza Drugs by Country
7.1.1 Europe Influenza Drugs Sales by Country (2018-2023)
7.1.2 Europe Influenza Drugs Revenue by Country (2018-2023)
7.2 Europe Influenza Drugs Sales by Type
7.3 Europe Influenza Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Influenza Drugs by Country
8.1.1 Middle East & Africa Influenza Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Influenza Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Influenza Drugs Sales by Type
8.3 Middle East & Africa Influenza Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Influenza Drugs
10.3 Manufacturing Process Analysis of Influenza Drugs
10.4 Industry Chain Structure of Influenza Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Influenza Drugs Distributors
11.3 Influenza Drugs Customer
12 WORLD FORECAST REVIEW FOR INFLUENZA DRUGS BY GEOGRAPHIC REGION
12.1 Global Influenza Drugs Market Size Forecast by Region
12.1.1 Global Influenza Drugs Forecast by Region (2024-2029)
12.1.2 Global Influenza Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Influenza Drugs Forecast by Type
12.7 Global Influenza Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bristol-Myers Squibb]
13.1.1 Bristol-Myers Squibb] Company Information
13.1.2 Bristol-Myers Squibb] Influenza Drugs Product Portfolios and Specifications
13.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bristol-Myers Squibb] Main Business Overview
13.1.5 Bristol-Myers Squibb] Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Influenza Drugs Product Portfolios and Specifications
13.2.3 AstraZeneca Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Eli Lilly
13.3.1 Eli Lilly Company Information
13.3.2 Eli Lilly Influenza Drugs Product Portfolios and Specifications
13.3.3 Eli Lilly Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Eli Lilly Main Business Overview
13.3.5 Eli Lilly Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Influenza Drugs Product Portfolios and Specifications
13.4.3 Roche Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Information
13.5.2 GlaxoSmithKline Influenza Drugs Product Portfolios and Specifications
13.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 GlaxoSmithKline Main Business Overview
13.5.5 GlaxoSmithKline Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Influenza Drugs Product Portfolios and Specifications
13.6.3 Novartis Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Influenza Drugs Product Portfolios and Specifications
13.7.3 Pfizer Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Sanofi Pasteur
13.8.1 Sanofi Pasteur Company Information
13.8.2 Sanofi Pasteur Influenza Drugs Product Portfolios and Specifications
13.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sanofi Pasteur Main Business Overview
13.8.5 Sanofi Pasteur Latest Developments
13.9 Bayer
13.9.1 Bayer Company Information
13.9.2 Bayer Influenza Drugs Product Portfolios and Specifications
13.9.3 Bayer Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bayer Main Business Overview
13.9.5 Bayer Latest Developments
13.10 Celgene
13.10.1 Celgene Company Information
13.10.2 Celgene Influenza Drugs Product Portfolios and Specifications
13.10.3 Celgene Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Celgene Main Business Overview
13.10.5 Celgene Latest Developments
13.11 Seqirus
13.11.1 Seqirus Company Information
13.11.2 Seqirus Influenza Drugs Product Portfolios and Specifications
13.11.3 Seqirus Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Seqirus Main Business Overview
13.11.5 Seqirus Latest Developments
13.12 Protein Sciences Corporation
13.12.1 Protein Sciences Corporation Company Information
13.12.2 Protein Sciences Corporation Influenza Drugs Product Portfolios and Specifications
13.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Protein Sciences Corporation Main Business Overview
13.12.5 Protein Sciences Corporation Latest Developments
13.13 Serum Institute of India
13.13.1 Serum Institute of India Company Information
13.13.2 Serum Institute of India Influenza Drugs Product Portfolios and Specifications
13.13.3 Serum Institute of India Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Serum Institute of India Main Business Overview
13.13.5 Serum Institute of India Latest Developments
13.14 Emergent Biosolutions
13.14.1 Emergent Biosolutions Company Information
13.14.2 Emergent Biosolutions Influenza Drugs Product Portfolios and Specifications
13.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Emergent Biosolutions Main Business Overview
13.14.5 Emergent Biosolutions Latest Developments
13.15 BioCryst Pharmaceuticals
13.15.1 BioCryst Pharmaceuticals Company Information
13.15.2 BioCryst Pharmaceuticals Influenza Drugs Product Portfolios and Specifications
13.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 BioCryst Pharmaceuticals Main Business Overview
13.15.5 BioCryst Pharmaceuticals Latest Developments
13.16 Alvogen
13.16.1 Alvogen Company Information
13.16.2 Alvogen Influenza Drugs Product Portfolios and Specifications
13.16.3 Alvogen Influenza Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Alvogen Main Business Overview
13.16.5 Alvogen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Influenza Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Influenza Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Zanamivir
Table 4. Major Players of Oseltamivir Phosphate
Table 5. Major Players of Peramivir
Table 6. Major Players of Other Influenza Drugs
Table 7. Global Influenza Drugs Sales by Type (2018-2023) & (K MT)
Table 8. Global Influenza Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Influenza Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Influenza Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Influenza Drugs Sale Price by Type (2018-2023) & (USD/MT)
Table 12. Global Influenza Drugs Sales by Application (2018-2023) & (K MT)
Table 13. Global Influenza Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Influenza Drugs Revenue by Application (2018-2023)
Table 15. Global Influenza Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Influenza Drugs Sale Price by Application (2018-2023) & (USD/MT)
Table 17. Global Influenza Drugs Sales by Company (2018-2023) & (K MT)
Table 18. Global Influenza Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Influenza Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Influenza Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Influenza Drugs Sale Price by Company (2018-2023) & (USD/MT)
Table 22. Key Manufacturers Influenza Drugs Producing Area Distribution and Sales Area
Table 23. Players Influenza Drugs Products Offered
Table 24. Influenza Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Influenza Drugs Sales by Geographic Region (2018-2023) & (K MT)
Table 28. Global Influenza Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Influenza Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Influenza Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Influenza Drugs Sales by Country/Region (2018-2023) & (K MT)
Table 32. Global Influenza Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Influenza Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Influenza Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Influenza Drugs Sales by Country (2018-2023) & (K MT)
Table 36. Americas Influenza Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Influenza Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Influenza Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Influenza Drugs Sales by Type (2018-2023) & (K MT)
Table 40. Americas Influenza Drugs Sales by Application (2018-2023) & (K MT)
Table 41. APAC Influenza Drugs Sales by Region (2018-2023) & (K MT)
Table 42. APAC Influenza Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Influenza Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Influenza Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Influenza Drugs Sales by Type (2018-2023) & (K MT)
Table 46. APAC Influenza Drugs Sales by Application (2018-2023) & (K MT)
Table 47. Europe Influenza Drugs Sales by Country (2018-2023) & (K MT)
Table 48. Europe Influenza Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Influenza Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Influenza Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Influenza Drugs Sales by Type (2018-2023) & (K MT)
Table 52. Europe Influenza Drugs Sales by Application (2018-2023) & (K MT)
Table 53. Middle East & Africa Influenza Drugs Sales by Country (2018-2023) & (K MT)
Table 54. Middle East & Africa Influenza Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Influenza Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Influenza Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Influenza Drugs Sales by Type (2018-2023) & (K MT)
Table 58. Middle East & Africa Influenza Drugs Sales by Application (2018-2023) & (K MT)
Table 59. Key Market Drivers & Growth Opportunities of Influenza Drugs
Table 60. Key Market Challenges & Risks of Influenza Drugs
Table 61. Key Industry Trends of Influenza Drugs
Table 62. Influenza Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Influenza Drugs Distributors List
Table 65. Influenza Drugs Customer List
Table 66. Global Influenza Drugs Sales Forecast by Region (2024-2029) & (K MT)
Table 67. Global Influenza Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Influenza Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 69. Americas Influenza Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Influenza Drugs Sales Forecast by Region (2024-2029) & (K MT)
Table 71. APAC Influenza Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Influenza Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 73. Europe Influenza Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Influenza Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 75. Middle East & Africa Influenza Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Influenza Drugs Sales Forecast by Type (2024-2029) & (K MT)
Table 77. Global Influenza Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Influenza Drugs Sales Forecast by Application (2024-2029) & (K MT)
Table 79. Global Influenza Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Bristol-Myers Squibb] Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Bristol-Myers Squibb] Influenza Drugs Product Portfolios and Specifications
Table 82. Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Bristol-Myers Squibb] Main Business
Table 84. Bristol-Myers Squibb] Latest Developments
Table 85. AstraZeneca Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. AstraZeneca Influenza Drugs Product Portfolios and Specifications
Table 87. AstraZeneca Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. AstraZeneca Main Business
Table 89. AstraZeneca Latest Developments
Table 90. Eli Lilly Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Eli Lilly Influenza Drugs Product Portfolios and Specifications
Table 92. Eli Lilly Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Eli Lilly Main Business
Table 94. Eli Lilly Latest Developments
Table 95. Roche Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Roche Influenza Drugs Product Portfolios and Specifications
Table 97. Roche Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. Roche Main Business
Table 99. Roche Latest Developments
Table 100. GlaxoSmithKline Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. GlaxoSmithKline Influenza Drugs Product Portfolios and Specifications
Table 102. GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. GlaxoSmithKline Main Business
Table 104. GlaxoSmithKline Latest Developments
Table 105. Novartis Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Novartis Influenza Drugs Product Portfolios and Specifications
Table 107. Novartis Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. Novartis Main Business
Table 109. Novartis Latest Developments
Table 110. Pfizer Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Pfizer Influenza Drugs Product Portfolios and Specifications
Table 112. Pfizer Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Pfizer Main Business
Table 114. Pfizer Latest Developments
Table 115. Sanofi Pasteur Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Sanofi Pasteur Influenza Drugs Product Portfolios and Specifications
Table 117. Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Sanofi Pasteur Main Business
Table 119. Sanofi Pasteur Latest Developments
Table 120. Bayer Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Bayer Influenza Drugs Product Portfolios and Specifications
Table 122. Bayer Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Bayer Main Business
Table 124. Bayer Latest Developments
Table 125. Celgene Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Celgene Influenza Drugs Product Portfolios and Specifications
Table 127. Celgene Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. Celgene Main Business
Table 129. Celgene Latest Developments
Table 130. Seqirus Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Seqirus Influenza Drugs Product Portfolios and Specifications
Table 132. Seqirus Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 133. Seqirus Main Business
Table 134. Seqirus Latest Developments
Table 135. Protein Sciences Corporation Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Protein Sciences Corporation Influenza Drugs Product Portfolios and Specifications
Table 137. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 138. Protein Sciences Corporation Main Business
Table 139. Protein Sciences Corporation Latest Developments
Table 140. Serum Institute of India Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Serum Institute of India Influenza Drugs Product Portfolios and Specifications
Table 142. Serum Institute of India Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 143. Serum Institute of India Main Business
Table 144. Serum Institute of India Latest Developments
Table 145. Emergent Biosolutions Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Emergent Biosolutions Influenza Drugs Product Portfolios and Specifications
Table 147. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 148. Emergent Biosolutions Main Business
Table 149. Emergent Biosolutions Latest Developments
Table 150. BioCryst Pharmaceuticals Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. BioCryst Pharmaceuticals Influenza Drugs Product Portfolios and Specifications
Table 152. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 153. BioCryst Pharmaceuticals Main Business
Table 154. BioCryst Pharmaceuticals Latest Developments
Table 155. Alvogen Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Alvogen Influenza Drugs Product Portfolios and Specifications
Table 157. Alvogen Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 158. Alvogen Main Business
Table 159. Alvogen Latest Developments
Table 1. Influenza Drugs Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Influenza Drugs Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Zanamivir
Table 4. Major Players of Oseltamivir Phosphate
Table 5. Major Players of Peramivir
Table 6. Major Players of Other Influenza Drugs
Table 7. Global Influenza Drugs Sales by Type (2018-2023) & (K MT)
Table 8. Global Influenza Drugs Sales Market Share by Type (2018-2023)
Table 9. Global Influenza Drugs Revenue by Type (2018-2023) & ($ million)
Table 10. Global Influenza Drugs Revenue Market Share by Type (2018-2023)
Table 11. Global Influenza Drugs Sale Price by Type (2018-2023) & (USD/MT)
Table 12. Global Influenza Drugs Sales by Application (2018-2023) & (K MT)
Table 13. Global Influenza Drugs Sales Market Share by Application (2018-2023)
Table 14. Global Influenza Drugs Revenue by Application (2018-2023)
Table 15. Global Influenza Drugs Revenue Market Share by Application (2018-2023)
Table 16. Global Influenza Drugs Sale Price by Application (2018-2023) & (USD/MT)
Table 17. Global Influenza Drugs Sales by Company (2018-2023) & (K MT)
Table 18. Global Influenza Drugs Sales Market Share by Company (2018-2023)
Table 19. Global Influenza Drugs Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Influenza Drugs Revenue Market Share by Company (2018-2023)
Table 21. Global Influenza Drugs Sale Price by Company (2018-2023) & (USD/MT)
Table 22. Key Manufacturers Influenza Drugs Producing Area Distribution and Sales Area
Table 23. Players Influenza Drugs Products Offered
Table 24. Influenza Drugs Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Influenza Drugs Sales by Geographic Region (2018-2023) & (K MT)
Table 28. Global Influenza Drugs Sales Market Share Geographic Region (2018-2023)
Table 29. Global Influenza Drugs Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Influenza Drugs Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Influenza Drugs Sales by Country/Region (2018-2023) & (K MT)
Table 32. Global Influenza Drugs Sales Market Share by Country/Region (2018-2023)
Table 33. Global Influenza Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Influenza Drugs Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Influenza Drugs Sales by Country (2018-2023) & (K MT)
Table 36. Americas Influenza Drugs Sales Market Share by Country (2018-2023)
Table 37. Americas Influenza Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Influenza Drugs Revenue Market Share by Country (2018-2023)
Table 39. Americas Influenza Drugs Sales by Type (2018-2023) & (K MT)
Table 40. Americas Influenza Drugs Sales by Application (2018-2023) & (K MT)
Table 41. APAC Influenza Drugs Sales by Region (2018-2023) & (K MT)
Table 42. APAC Influenza Drugs Sales Market Share by Region (2018-2023)
Table 43. APAC Influenza Drugs Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Influenza Drugs Revenue Market Share by Region (2018-2023)
Table 45. APAC Influenza Drugs Sales by Type (2018-2023) & (K MT)
Table 46. APAC Influenza Drugs Sales by Application (2018-2023) & (K MT)
Table 47. Europe Influenza Drugs Sales by Country (2018-2023) & (K MT)
Table 48. Europe Influenza Drugs Sales Market Share by Country (2018-2023)
Table 49. Europe Influenza Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Influenza Drugs Revenue Market Share by Country (2018-2023)
Table 51. Europe Influenza Drugs Sales by Type (2018-2023) & (K MT)
Table 52. Europe Influenza Drugs Sales by Application (2018-2023) & (K MT)
Table 53. Middle East & Africa Influenza Drugs Sales by Country (2018-2023) & (K MT)
Table 54. Middle East & Africa Influenza Drugs Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Influenza Drugs Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Influenza Drugs Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Influenza Drugs Sales by Type (2018-2023) & (K MT)
Table 58. Middle East & Africa Influenza Drugs Sales by Application (2018-2023) & (K MT)
Table 59. Key Market Drivers & Growth Opportunities of Influenza Drugs
Table 60. Key Market Challenges & Risks of Influenza Drugs
Table 61. Key Industry Trends of Influenza Drugs
Table 62. Influenza Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Influenza Drugs Distributors List
Table 65. Influenza Drugs Customer List
Table 66. Global Influenza Drugs Sales Forecast by Region (2024-2029) & (K MT)
Table 67. Global Influenza Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Influenza Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 69. Americas Influenza Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Influenza Drugs Sales Forecast by Region (2024-2029) & (K MT)
Table 71. APAC Influenza Drugs Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Influenza Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 73. Europe Influenza Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Influenza Drugs Sales Forecast by Country (2024-2029) & (K MT)
Table 75. Middle East & Africa Influenza Drugs Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Influenza Drugs Sales Forecast by Type (2024-2029) & (K MT)
Table 77. Global Influenza Drugs Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Influenza Drugs Sales Forecast by Application (2024-2029) & (K MT)
Table 79. Global Influenza Drugs Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Bristol-Myers Squibb] Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Bristol-Myers Squibb] Influenza Drugs Product Portfolios and Specifications
Table 82. Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Bristol-Myers Squibb] Main Business
Table 84. Bristol-Myers Squibb] Latest Developments
Table 85. AstraZeneca Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. AstraZeneca Influenza Drugs Product Portfolios and Specifications
Table 87. AstraZeneca Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. AstraZeneca Main Business
Table 89. AstraZeneca Latest Developments
Table 90. Eli Lilly Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Eli Lilly Influenza Drugs Product Portfolios and Specifications
Table 92. Eli Lilly Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Eli Lilly Main Business
Table 94. Eli Lilly Latest Developments
Table 95. Roche Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Roche Influenza Drugs Product Portfolios and Specifications
Table 97. Roche Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. Roche Main Business
Table 99. Roche Latest Developments
Table 100. GlaxoSmithKline Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. GlaxoSmithKline Influenza Drugs Product Portfolios and Specifications
Table 102. GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. GlaxoSmithKline Main Business
Table 104. GlaxoSmithKline Latest Developments
Table 105. Novartis Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Novartis Influenza Drugs Product Portfolios and Specifications
Table 107. Novartis Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. Novartis Main Business
Table 109. Novartis Latest Developments
Table 110. Pfizer Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Pfizer Influenza Drugs Product Portfolios and Specifications
Table 112. Pfizer Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Pfizer Main Business
Table 114. Pfizer Latest Developments
Table 115. Sanofi Pasteur Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Sanofi Pasteur Influenza Drugs Product Portfolios and Specifications
Table 117. Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Sanofi Pasteur Main Business
Table 119. Sanofi Pasteur Latest Developments
Table 120. Bayer Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Bayer Influenza Drugs Product Portfolios and Specifications
Table 122. Bayer Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Bayer Main Business
Table 124. Bayer Latest Developments
Table 125. Celgene Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Celgene Influenza Drugs Product Portfolios and Specifications
Table 127. Celgene Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. Celgene Main Business
Table 129. Celgene Latest Developments
Table 130. Seqirus Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. Seqirus Influenza Drugs Product Portfolios and Specifications
Table 132. Seqirus Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 133. Seqirus Main Business
Table 134. Seqirus Latest Developments
Table 135. Protein Sciences Corporation Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Protein Sciences Corporation Influenza Drugs Product Portfolios and Specifications
Table 137. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 138. Protein Sciences Corporation Main Business
Table 139. Protein Sciences Corporation Latest Developments
Table 140. Serum Institute of India Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Serum Institute of India Influenza Drugs Product Portfolios and Specifications
Table 142. Serum Institute of India Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 143. Serum Institute of India Main Business
Table 144. Serum Institute of India Latest Developments
Table 145. Emergent Biosolutions Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Emergent Biosolutions Influenza Drugs Product Portfolios and Specifications
Table 147. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 148. Emergent Biosolutions Main Business
Table 149. Emergent Biosolutions Latest Developments
Table 150. BioCryst Pharmaceuticals Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. BioCryst Pharmaceuticals Influenza Drugs Product Portfolios and Specifications
Table 152. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 153. BioCryst Pharmaceuticals Main Business
Table 154. BioCryst Pharmaceuticals Latest Developments
Table 155. Alvogen Basic Information, Influenza Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Alvogen Influenza Drugs Product Portfolios and Specifications
Table 157. Alvogen Influenza Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 158. Alvogen Main Business
Table 159. Alvogen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Influenza Drugs
Figure 2. Influenza Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Drugs Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Influenza Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Influenza Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Zanamivir
Figure 10. Product Picture of Oseltamivir Phosphate
Figure 11. Product Picture of Peramivir
Figure 12. Product Picture of Other Influenza Drugs
Figure 13. Global Influenza Drugs Sales Market Share by Type in 2022
Figure 14. Global Influenza Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Influenza Drugs Consumed in Adults
Figure 16. Global Influenza Drugs Market: Adults (2018-2023) & (K MT)
Figure 17. Influenza Drugs Consumed in Chidren
Figure 18. Global Influenza Drugs Market: Chidren (2018-2023) & (K MT)
Figure 19. Global Influenza Drugs Sales Market Share by Application (2022)
Figure 20. Global Influenza Drugs Revenue Market Share by Application in 2022
Figure 21. Influenza Drugs Sales Market by Company in 2022 (K MT)
Figure 22. Global Influenza Drugs Sales Market Share by Company in 2022
Figure 23. Influenza Drugs Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Influenza Drugs Revenue Market Share by Company in 2022
Figure 25. Global Influenza Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Influenza Drugs Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Influenza Drugs Sales 2018-2023 (K MT)
Figure 28. Americas Influenza Drugs Revenue 2018-2023 ($ Millions)
Figure 29. APAC Influenza Drugs Sales 2018-2023 (K MT)
Figure 30. APAC Influenza Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Europe Influenza Drugs Sales 2018-2023 (K MT)
Figure 32. Europe Influenza Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Influenza Drugs Sales 2018-2023 (K MT)
Figure 34. Middle East & Africa Influenza Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Americas Influenza Drugs Sales Market Share by Country in 2022
Figure 36. Americas Influenza Drugs Revenue Market Share by Country in 2022
Figure 37. Americas Influenza Drugs Sales Market Share by Type (2018-2023)
Figure 38. Americas Influenza Drugs Sales Market Share by Application (2018-2023)
Figure 39. United States Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Influenza Drugs Sales Market Share by Region in 2022
Figure 44. APAC Influenza Drugs Revenue Market Share by Regions in 2022
Figure 45. APAC Influenza Drugs Sales Market Share by Type (2018-2023)
Figure 46. APAC Influenza Drugs Sales Market Share by Application (2018-2023)
Figure 47. China Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Influenza Drugs Sales Market Share by Country in 2022
Figure 55. Europe Influenza Drugs Revenue Market Share by Country in 2022
Figure 56. Europe Influenza Drugs Sales Market Share by Type (2018-2023)
Figure 57. Europe Influenza Drugs Sales Market Share by Application (2018-2023)
Figure 58. Germany Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Influenza Drugs Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Influenza Drugs Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Influenza Drugs Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Influenza Drugs Sales Market Share by Application (2018-2023)
Figure 67. Egypt Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Influenza Drugs in 2022
Figure 73. Manufacturing Process Analysis of Influenza Drugs
Figure 74. Industry Chain Structure of Influenza Drugs
Figure 75. Channels of Distribution
Figure 76. Global Influenza Drugs Sales Market Forecast by Region (2024-2029)
Figure 77. Global Influenza Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Influenza Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Influenza Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Influenza Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Influenza Drugs Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Influenza Drugs
Figure 2. Influenza Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Drugs Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Influenza Drugs Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Influenza Drugs Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Zanamivir
Figure 10. Product Picture of Oseltamivir Phosphate
Figure 11. Product Picture of Peramivir
Figure 12. Product Picture of Other Influenza Drugs
Figure 13. Global Influenza Drugs Sales Market Share by Type in 2022
Figure 14. Global Influenza Drugs Revenue Market Share by Type (2018-2023)
Figure 15. Influenza Drugs Consumed in Adults
Figure 16. Global Influenza Drugs Market: Adults (2018-2023) & (K MT)
Figure 17. Influenza Drugs Consumed in Chidren
Figure 18. Global Influenza Drugs Market: Chidren (2018-2023) & (K MT)
Figure 19. Global Influenza Drugs Sales Market Share by Application (2022)
Figure 20. Global Influenza Drugs Revenue Market Share by Application in 2022
Figure 21. Influenza Drugs Sales Market by Company in 2022 (K MT)
Figure 22. Global Influenza Drugs Sales Market Share by Company in 2022
Figure 23. Influenza Drugs Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Influenza Drugs Revenue Market Share by Company in 2022
Figure 25. Global Influenza Drugs Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Influenza Drugs Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Influenza Drugs Sales 2018-2023 (K MT)
Figure 28. Americas Influenza Drugs Revenue 2018-2023 ($ Millions)
Figure 29. APAC Influenza Drugs Sales 2018-2023 (K MT)
Figure 30. APAC Influenza Drugs Revenue 2018-2023 ($ Millions)
Figure 31. Europe Influenza Drugs Sales 2018-2023 (K MT)
Figure 32. Europe Influenza Drugs Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Influenza Drugs Sales 2018-2023 (K MT)
Figure 34. Middle East & Africa Influenza Drugs Revenue 2018-2023 ($ Millions)
Figure 35. Americas Influenza Drugs Sales Market Share by Country in 2022
Figure 36. Americas Influenza Drugs Revenue Market Share by Country in 2022
Figure 37. Americas Influenza Drugs Sales Market Share by Type (2018-2023)
Figure 38. Americas Influenza Drugs Sales Market Share by Application (2018-2023)
Figure 39. United States Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Influenza Drugs Sales Market Share by Region in 2022
Figure 44. APAC Influenza Drugs Revenue Market Share by Regions in 2022
Figure 45. APAC Influenza Drugs Sales Market Share by Type (2018-2023)
Figure 46. APAC Influenza Drugs Sales Market Share by Application (2018-2023)
Figure 47. China Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Influenza Drugs Sales Market Share by Country in 2022
Figure 55. Europe Influenza Drugs Revenue Market Share by Country in 2022
Figure 56. Europe Influenza Drugs Sales Market Share by Type (2018-2023)
Figure 57. Europe Influenza Drugs Sales Market Share by Application (2018-2023)
Figure 58. Germany Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Influenza Drugs Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Influenza Drugs Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Influenza Drugs Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Influenza Drugs Sales Market Share by Application (2018-2023)
Figure 67. Egypt Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Influenza Drugs Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Influenza Drugs in 2022
Figure 73. Manufacturing Process Analysis of Influenza Drugs
Figure 74. Industry Chain Structure of Influenza Drugs
Figure 75. Channels of Distribution
Figure 76. Global Influenza Drugs Sales Market Forecast by Region (2024-2029)
Figure 77. Global Influenza Drugs Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Influenza Drugs Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Influenza Drugs Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Influenza Drugs Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Influenza Drugs Revenue Market Share Forecast by Application (2024-2029)
